| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10070445 | European Journal of Surgical Oncology (EJSO) | 2005 | 6 Pages |
Abstract
DCE-MRI is able to accurately predict those patients suitable for breast conserving surgery following neoadjuvant chemotherapy and should be the imaging modality of choice in assessing the response of patients with primary breast carcinoma to neoadjuvant chemotherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
T. Julius, S.E.G. Kemp, P.J. Kneeshaw, A. Chaturvedi, P.J. Drew, L.W. Turnbull,